US$ 22.88
tirzepatide glp 1 Compound Lose up to 20% of your body weight with this simple Understand GLP-1/GIP Dual Agonist Tirzepatide
Description
The global market for GLP-1 weight-loss medications alone was valued at around $13.84 billion in 2024 and is expected to grow at a compound annual growth rate (CAGR) of 18.54%, reaching nearly $48.84 billion by 2030

Twoyear effects of semaglutide in adults with overweight or obesity: the STEP 5 trial

doi: 10.1056/NEJMoa1504720 4 NealBPerkovicVMahaffeyKWde ZeeuwDFulcherGEronduNet al

Association between Serum Thyrotropin within the Euthyroid Range and Obesity

Sustained release is achieved by incorporating exendin-4 into 0.06 mm diameter biodegradable microspheres containing 50:50 poly (D,L-lactide-co-glycolide) (PLG) polymer and sucrose

Research has shown that implanting DPCs into skin can even generate new hair follicles, highlighting their potential for regenerative therapies
